Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsIn 2026, Fuji Pharma has already paid €0.12 in dividends. The last payout was in June.
Financials
In the last quarter, Fuji Pharma had revenue of €95.28M and net profit of €5.66M
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 95.28M | 12.40% |
| Gross profit | 37.28M | 7.73% |
| Net profit | 5.66M | 15.91% |
| EBITDA | 5.38M | 64.47% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €257.78M |
Number of shares | 26.12M |
52-week high/low | €14.71 - €9.69 |
Dividend yield | 2.47% |
Dividends TTM | €0.26 |
Next dividend | €0.15 |
Beta | 0.34 |
P/E ratio | 15.58 |
PEG ratio | -1.51 |
P/B ratio | 0.85 |
P/S ratio | 0.72 |
Company profile
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
| Name | Fuji Pharma |
| CEO | Shuhei Morita |
| Headquarters | Tokyo,
ty Japan |
| Website | |
| IPO | 02/22/2010 |
| Employees | 1,760 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 4554.T |
Frankfurt | FUP.F |
Düsseldorf | FUP.DU |